EXHIBIT (a)(3)Pharmainvest LLC • August 21st, 1997 • Biological products, (no disgnostic substances)
Company FiledAugust 21st, 1997 Industry
OFFER TO PURCHASE FOR CASH UP TO 160 OUTSTANDING CONTRACTUAL CONTINGENT PAYMENT RIGHTS (THE "CCPRs") ARISING FROM THE PURCHASE OF CLASS A INTERESTS OF AMGEN CLINICAL PARTNERS, L.P. AT $240,000 NET PER CCPR BY PHARMAINVEST, L.L.C.Pharmainvest LLC • August 21st, 1997 • Biological products, (no disgnostic substances)
Company FiledAugust 21st, 1997 Industry